What if there is production happening in the US but it is not Spider Silk

 

From the June 29th Release:

 

Global silk production is expected to reach USD 17 billion in 2021; the economic impact of eliminating the loss from disease is a multi-billion dollar opportunity. The Company anticipates that its development of a disease resistant silkworm could be licensed across the entire global silk industry.

“Our work to enhance the disease resistance of our silkworms complements and strengths our focus in bringing our recombinant spider silk to market,” said CEO and Founder, Kim Thompson. “We believe that success in this effort will also provide significant opportunities for growth far beyond the reach of Kraig’s in-house production capacity, with licensing applications globally.”

Once proven, the Company expects to merge these disease resistance properties within its existing lines of genetically enhanced recombinant spider silks.

----

Could there be some success in this area that would generate revenue for KBLB. Even if we are in a QP, wouldn't that show up in the 10-Q that would be out end of October.